People | April 06, 2026
Sanofi appoints Dr Parikshit Chaudhari as Head of Market Access & Pricing Strategy
He brings extensive cross-functional expertise built through leadership roles
He brings extensive cross-functional expertise built through leadership roles
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign
The SirPAD trial marks a significant milestone in vascular intervention, positioning MagicTouch PTA as a promising future alternative for PAD treatment
Key FDA decisions and pivotal late-stage obesity and breast cancer data could reshape competitive positioning
The trial, dubbed MALBEC, marks the first in a broader late-phase development push for MK-8748, with a second NVAMD study expected to begin later this year
Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
The price revision, effective April 3, 2026, brings the innovator molecule within the reach of a significantly larger patient base across the country
Subscribe To Our Newsletter & Stay Updated
